NEW YORK, Nov 14 – Incyte has signed a three-year agreement with Galapagos Genomics to develop and market an adenoviral gene expression platform, the companies announced Tuesday.
NEW YORK, Nov 14 – Incyte has signed a three-year agreement with Galapagos Genomics to develop and market an adenoviral gene expression platform, the companies announced Tuesday.